Head and neck cancer immunotherapy drug prolongs life and is less toxic
Researchers say that immunotherapy could help neck and head cancer sufferers to live longer after a recent trial took place. The drug pembrolizumab, was given to 882 patients from around the world who were diagnosed with advanced head and neck cancer. It managed to keep the cancers at bay for an average of two years. […]